Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients

Lee, MengMengLeeChen, Chi-Hsin SallyChi-Hsin SallyChenOvbiagele, BruceBruceOvbiagele2020-05-202020-05-202020-07-15https://scholars.lib.ntu.edu.tw/handle/123456789/493805enCOVID-19StrokeMedication discontinuation[SDGs]SDG3Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patientsjournal article10.1016/j.jns.2020.116883